Form 8-K

8-K — Caring Brands, Inc.

Accession: 0001493152-26-026533

Filed: 2026-06-01

Period: 2026-06-01

CIK: 0002020737

SIC: 2844 (PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS)

Item: Regulation FD Disclosure

Item: Financial Statements and Exhibits

Documents

8-K — form8-k.htm (Primary)

EX-99.1 (ex99-1.htm)

GRAPHIC (ex99-1_001.jpg)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K

8-K (Primary)

Filename: form8-k.htm · Sequence: 1

false

0002020737

2026-06-01

iso4217:USD

xbrli:shares

iso4217:USD

xbrli:shares

UNITED

STATES

SECURITIES

AND EXCHANGE COMMISSION

WASHINGTON,

D.C. 20549

FORM

8-K

CURRENT

REPORT

PURSUANT

TO SECTION 13 OR 15(d) OF THE

SECURITIES

EXCHANGE ACT OF 1934

Date

of Report (Date of earliest event reported): June

1, 2026

Caring

Brands, Inc.

(Exact

name of registrant as specified in its charter)

Nevada

001-42941

99-4103908

(State

or other jurisdiction

incorporation)

(Commission

File

Number)

(IRS

Employer

Identification

No.)

130

S Indian River Drive,

Suite

202 pbm# 1232,

Fort

Pierce, FL

34950

(Address

of principal executive offices, including zip code)

Registrant’s

telephone number, including area code: (561)

896-7616

Not

Applicable

(Former

name or former address, if changed since last report)

Check

the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under

any of the following provisions:

☐

Written

communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting

material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement

communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement

communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities

registered pursuant to Section 12(b) of the Act:

Title

of each class

Trading

Symbol(s)

Name

of each exchange on which registered

Common

Stock, par value $0.001 per share

CABR

The

Nasdaq

Stock Market LLC

Indicate

by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405

of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging

growth company ☒

an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying

with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item

7.01 Other Events.

June 1, 2026, Caring Brands, Inc., a Nevada corporation, (the “Company”), issued a press release. . A copy of the

press release is filed as Exhibit 99.1 to this Current Report and incorporated herein by reference.

Item

9.01 Financial Statements and Exhibits.

(d)

Exhibits

The

following exhibits are being filed herewith:

Exhibit

No.

Description

99.1

Press Release, dated June 1, 2026

104

Cover

Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURE

Pursuant

to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by

the undersigned hereunto duly authorized.

Dated:

June 1, 2026

Caring

Brands, Inc.

By:

/s/

Glynn Wilson

Name:

Dr.

Glynn Wilson

Title:

Chief

Executive Officer

EX-99.1

Filename: ex99-1.htm · Sequence: 2

Exhibit

99.1

Caring

Brands Inc. and SanPellegrino Cosmetics Private Limited Announce Expanded Multi-Territory Licensing Agreement for Photocil and Hair Enzyme

Booster

Five-Year

Agreement Extends Commercial Reach Across India, LATAM, Russia, Australia and New Zealand

Fort

Pierce, Fla. (GLOBE NEWSWIRE – June 01, 2026) — Caring Brands Inc. (Nasdaq: CABR), a consumer brands company specializing

in skin care and hair growth, and SanPellegrino Cosmetics Private Limited (“SCPL”), a New Delhi-based specialty pharma and

dermatology licensing company, today announced the execution of a revised multi-territory licensing agreement covering Photocil and Hair

Enzyme Booster.

The

revised agreement, effective May 21, 2026, builds on over three years of successful commercialization and expands the scope and term

of the parties’ existing commercial relationship across key global markets. Both Photocil and Hair Enzyme Booster are currently

manufactured in India.

Since

their launch in India, both Photocil and Hair Enzyme Booster have demonstrated good commercial performance and clinical acceptance across

the dermatology and hair science communities. Photocil — commercialized as Photofirst by Eris Lifesciences, (“Eris”)

one of India’s leading specialty pharma companies — has established itself as a clinically differentiated option for dermatologists

treating vitiligo, psoriasis, and atopic dermatitis. The Hair Enzyme Booster has begun to achieve significant traction across India and

Asia, having been licensed by SCPL to some of the world’s largest hair science and pharmaceutical brands including Dr. Reddy’s

Laboratories, Cipla, Dabur, Eris Lifesciences, and Glenmark Pharmaceuticals, which we believe underscores the technology’s broad

global commercial validation.

The

revised agreement grants SCPL an extended five-year initial term with automatic annual renewal. The expanded territory set now covers

India (existing), LATAM (Mexico, Brazil, Colombia, Ecuador, Peru, Dominican Republic, Trinidad and Tobago), Russia, and Australia and

New Zealand. SCPL’s existing sublicense partnerships include Eris in India and Glenmark Pharmaceuticals across Asia and the Middle

East, where Hair Enzyme Booster has been registered or is in active regulatory review across multiple markets including Malaysia, Vietnam,

Cambodia, UAE, Kuwait, and Saudi Arabia — reflecting a well-established regional commercialization footprint that underpins the

expanded agreement.

Photocil

is a clinically validated, patented topical formulation developed to support the treatment of vitiligo, psoriasis, and atopic dermatitis.

Hair Enzyme Booster is a first-of-its-kind, patented topical formulation shown in clinical studies to increase levels of the SULT1A1

(Sulfotransferase) enzyme, which is essential for converting Minoxidil into its active form, Minoxidil Sulfate, thereby promoting hair

growth.

Dr.

Glynn Wilson, CEO of Caring Brands, commented, “This expanded agreement reflects our confidence in SCPL’s commercial execution

and our shared vision for bringing these clinically validated technologies to patients across high-growth international markets in order

to improve our revenue stream.”

Arjun

Khurana, Founder and Director of SanPellegrino Cosmetics Private Limited, said, “Over the past three years, we have built a strong

foundation for both Photocil and Hair Enzyme Booster across India and Asia, supported by a robust network of leading pharmaceutical partners

and a growing body of real-world clinical evidence. This expanded agreement positions us to bring these differentiated dermatology technologies

to a significantly broader patient population across LATAM, Russia, Australia, and New Zealand.”

About

Caring Brands

Caring

Brands Inc. has a growing portfolio of unique, patented, and clinically validated products for skin and hair growth. The Company intends

to launch a total of five products over the next two years in addition to in-licensing additional products. Management has a successful

track record of strategic acquisitions, rapid product development, IP development and product licensing. Revenues from the sales of Hair

Enzyme Booster for the treatment of hair loss, and Photocil for the treatment of psoriasis and vitiligo, are currently being generated

by direct sales in the US and licensees in India. Additional product opportunities include CB-101 for the treatment of eczema, NoStingz,

a sunscreen that prevents jellyfish stings.

About

SanPellegrino Cosmetics Private Limited

SanPellegrino

Cosmetics Private Limited (SCPL) is a New Delhi-based specialty pharma and dermatology licensing company operating across India, LATAM,

MENA, ANZ, SEA, CIS, and Korea. SCPL sub-licenses clinically proven technologies in dermatology and hair science through established

partnerships with leading regional pharmaceutical companies including Eris Lifesciences and Glenmark Pharmaceuticals. For more information,

visit www.spcindia.net.

Contact

Caring

Brands

Brian S John

Chief Investment Officer

(561) 896-7616

SanPellegrino

Cosmetics Private Limited

Arjun

Khurana,

Founder & Director

arjunkhurana@spcindia.net

www.spcindia.net

www.photociltherapy.com

Forward-Looking

Statements

This

communication contains forward-looking statements within the meaning of the federal securities laws regarding Caring Brands, Inc. (“Company”),

including, without limitation, statements regarding the anticipated timing of studies and the expected results, benefits and potential

outcomes thereof. You can generally identify forward-looking statements by the use of forward-looking terminology such as “anticipate,”

“believe,” “continue,” “could,” “estimate,” “expect,” “explore,”

“evaluate,” “intend,” “may,” “might,” “plan,” “potential,” “predict,”

“project,” “seek,” “should,” or “will,” or the negative of such terms thereof or other

variations thereon or comparable terminology, although not all forward-looking statements contain these identifying words.

These

forward-looking statements are based on each of the Company’s current plans, objectives, estimates, expectations, and intentions

and inherently involve significant risks and uncertainties, many of which are beyond our control. Actual results, performance or achievements,

including the timing of events, may differ materially from those expressed or implied by the forward-looking statements as a result of

various risks and uncertainties, including those described under the heading “Risk Factors” in the Company’s filings

with the Securities and Exchange Commission, including its most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and

other subsequent filings with the SEC. Copies of these filings are available on the SEC’s website at www.sec.gov. Investors

are cautioned that forward-looking statements are not guarantees of future performance, and are cautioned not to place undue reliance

on any such forward-looking statements. The forward-looking statements made in this communication are made only as of the date hereof

or as of the dates indicated in the forward-looking statements and reflect the views stated therein with respect to future events at

such dates, even if they are subsequently made available by the Company on its website or otherwise. The Company undertakes no obligation

to update, revise or supplement any forward-looking statements to reflect actual results, new information, future events, changes in

its expectations or other circumstances occurring after the date such statements were made, except as required by applicable law.

GRAPHIC

Filename: ex99-1_001.jpg · Sequence: 3

Binary file (3093 bytes)

Download ex99-1_001.jpg

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 8

v3.26.1

Cover

Jun. 01, 2026

Cover [Abstract]

Document Type

8-K

Amendment Flag

false

Document Period End Date

Jun. 01, 2026

Entity File Number

001-42941

Entity Registrant Name

Caring

Brands, Inc.

Entity Central Index Key

0002020737

Entity Tax Identification Number

99-4103908

Entity Incorporation, State or Country Code

Entity Address, Address Line One

130

S Indian River Drive

Entity Address, Address Line Two

Suite

202 pbm# 1232

Entity Address, City or Town

Fort

Pierce

Entity Address, State or Province

Entity Address, Postal Zip Code

34950

City Area Code

(561)

Local Phone Number

896-7616

Written Communications

false

Soliciting Material

false

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Title of 12(b) Security

Common

Stock, par value $0.001 per share

Trading Symbol

CABR

Security Exchange Name

NASDAQ

Entity Emerging Growth Company

true

Elected Not To Use the Extended Transition Period

false

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Cover page.

+ References

No definition available.

+ Details

Name:

dei_CoverAbstract

Namespace Prefix:

dei_

Data Type:

xbrli:stringItemType

Balance Type:

Period Type:

duration

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

Period Type:

duration

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 2 such as Street or Suite number

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine2

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

Period Type:

duration

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 7A

-Section B

-Subsection 2

+ Details

Name:

dei_EntityExTransitionPeriod

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

Period Type:

duration

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

Period Type:

duration

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

Period Type:

duration

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

Period Type:

duration

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration